Skip to main content

Showing 1–5 of 5 results for author: Igashov, I

Searching in archive cs. Search in all archives.
.
  1. arXiv:2308.16212  [pdf, other

    q-bio.QM cs.LG q-bio.BM

    RetroBridge: Modeling Retrosynthesis with Markov Bridges

    Authors: Ilia Igashov, Arne Schneuing, Marwin Segler, Michael Bronstein, Bruno Correia

    Abstract: Retrosynthesis planning is a fundamental challenge in chemistry which aims at designing reaction pathways from commercially available starting materials to a target molecule. Each step in multi-step retrosynthesis planning requires accurate prediction of possible precursor molecules given the target molecule and confidence estimates to guide heuristic search algorithms. We model single-step retros… ▽ More

    Submitted 26 March, 2024; v1 submitted 30 August, 2023; originally announced August 2023.

  2. arXiv:2210.13695  [pdf, other

    q-bio.BM cs.LG

    Structure-based Drug Design with Equivariant Diffusion Models

    Authors: Arne Schneuing, Yuanqi Du, Charles Harris, Arian Jamasb, Ilia Igashov, Weitao Du, Tom Blundell, Pietro Lió, Carla Gomes, Max Welling, Michael Bronstein, Bruno Correia

    Abstract: Structure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets. In this paper, we formulate SBDD as a 3D-conditional generation problem and present DiffSBDD, an SE(3)-equivariant 3D-conditional diffusion model that generates novel ligands conditioned on protein pockets. Comprehensive in silico experiments demo… ▽ More

    Submitted 30 June, 2023; v1 submitted 24 October, 2022; originally announced October 2022.

  3. arXiv:2210.05274  [pdf, other

    cs.LG q-bio.BM

    Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design

    Authors: Ilia Igashov, Hannes Stärk, Clément Vignac, Victor Garcia Satorras, Pascal Frossard, Max Welling, Michael Bronstein, Bruno Correia

    Abstract: Fragment-based drug discovery has been an effective paradigm in early-stage drug development. An open challenge in this area is designing linkers between disconnected molecular fragments of interest to obtain chemically-relevant candidate drug molecules. In this work, we propose DiffLinker, an E(3)-equivariant 3D-conditional diffusion model for molecular linker design. Given a set of disconnected… ▽ More

    Submitted 11 October, 2022; originally announced October 2022.

    Comments: Under review

  4. arXiv:2107.12078  [pdf, other

    q-bio.QM cs.LG eess.SP

    6DCNN with roto-translational convolution filters for volumetric data processing

    Authors: Dmitrii Zhemchuzhnikov, Ilia Igashov, Sergei Grudinin

    Abstract: In this work, we introduce 6D Convolutional Neural Network (6DCNN) designed to tackle the problem of detecting relative positions and orientations of local patterns when processing three-dimensional volumetric data. 6DCNN also includes SE(3)-equivariant message-passing and nonlinear activation operations constructed in the Fourier space. Working in the Fourier space allows significantly reducing t… ▽ More

    Submitted 30 July, 2021; v1 submitted 26 July, 2021; originally announced July 2021.

  5. arXiv:2011.07980  [pdf, other

    q-bio.QM cs.LG

    Spherical convolutions on molecular graphs for protein model quality assessment

    Authors: Ilia Igashov, Nikita Pavlichenko, Sergei Grudinin

    Abstract: Processing information on 3D objects requires methods stable to rigid-body transformations, in particular rotations, of the input data. In image processing tasks, convolutional neural networks achieve this property using rotation-equivariant operations. However, contrary to images, graphs generally have irregular topology. This makes it challenging to define a rotation-equivariant convolution oper… ▽ More

    Submitted 6 January, 2021; v1 submitted 16 November, 2020; originally announced November 2020.